{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:06:18Z","timestamp":1792112778909,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Central Region Hospital Alliance, Department of Health","award":["9916"],"award-info":[{"award-number":["9916"]}]},{"name":"Taipei Medical University-Wan Fang Hospital","award":["103-wf-eva-01"],"award-info":[{"award-number":["103-wf-eva-01"]}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC 102-2314-B-038-047-MY2"],"award-info":[{"award-number":["NSC 102-2314-B-038-047-MY2"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.pnpbp.2014.12.001","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T07:49:02Z","timestamp":1418111342000},"page":"47-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin"],"prefix":"10.1016","volume":"58","author":[{"given":"Mong-Liang","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsu-Nai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsang-Yaw","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chuan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Huang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Yu","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Feng","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-To","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Chin-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2014.12.001_bb0005","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.03.014","article-title":"Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study","volume":"111","author":"Bai","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1192\/bjp.bp.109.067512","article-title":"Twenty-five year mortality of a community cohort with schizophrenia","volume":"196","author":"Brown","year":"2010","journal-title":"Br J Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.pnpbp.2014.12.001_bb0020","first-page":"15S","article-title":"Metabolic issues and cardiovascular disease in patients with psychiatric disorders","volume":"118","author":"Casey","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0025","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.pnpbp.2011.01.010","article-title":"Weight gain and ghrelin level after olanzapine monotherapy","volume":"35","author":"Chen","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2009.11.009","article-title":"The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain?","volume":"34","author":"Deng","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0035","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.pnpbp.2008.03.015","article-title":"Effects of second generation antipsychotics on leptin and ghrelin","volume":"32","author":"Esen-Danaci","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0040","first-page":"493","article-title":"Metabolic parameters and long-term antipsychotic treatment: a comparison between patients treated with clozapine or olanzapine","volume":"33","author":"Feng","year":"2012","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0045","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0050","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1172\/JCI45888","article-title":"Sixteen years and counting: an update on leptin in energy balance","volume":"121","author":"Gautron","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1192\/bjp.179.1.59","article-title":"Effects of long-term treatment with antipsychotics on serum leptin levels","volume":"179","author":"Herran","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000086171","article-title":"Ghrelin plasma levels during psychopharmacological treatment","volume":"52","author":"Himmerich","year":"2005","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0065","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1210\/endo.142.10.8490","article-title":"Minireview: ghrelin and the regulation of energy balance\u2014a hypothalamic perspective","volume":"142","author":"Horvath","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0269881105056647","article-title":"Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia","volume":"20","author":"Hosojima","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0075","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1600-0447.2009.01401.x","article-title":"Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan","volume":"120","author":"Huang","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0080","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.metabol.2008.03.019","article-title":"Low serum adiponectin level as a predictor of impaired glucose regulation and type 2 diabetes mellitus in a middle-aged Finnish population","volume":"57","author":"Jalovaara","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.schres.2007.11.026","article-title":"Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin","volume":"100","author":"Jin","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0090","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0095","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.psyneuen.2008.08.016","article-title":"Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever","volume":"34","author":"Kluge","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.schres.2009.02.006","article-title":"Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol","volume":"110","author":"Krakowski","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0105","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1210\/jc.2003-031471","article-title":"Circulating ghrelin is sensitive to changes in body weight during a diet and exercise program in normal-weight young women","volume":"89","author":"Leidy","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-003-1529-4","article-title":"Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses","volume":"170","author":"Melkersson","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0120","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.psyneuen.2007.05.007","article-title":"Acute administration of clozapine concurrently increases blood glucose and circulating plasma ghrelin levels in rats","volume":"32","author":"Murashita","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.mp.4002066","article-title":"Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles","volume":"13","author":"Nasrallah","year":"2008","journal-title":"Mol Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2014.12.001_bb0130","first-page":"20","article-title":"Metabolic considerations in the use of antipsychotic medications: a review of recent evidence","volume":"68","author":"Newcomer","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2014.12.001_bb0135","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.diabres.2005.03.008","article-title":"Correlation of serum ghrelin levels with body mass index and carbohydrate metabolism in patients treated with atypical antipsychotics","volume":"68","author":"Palik","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","article-title":"Metabolic side effects of antipsychotic drug treatment\u2014pharmacological mechanisms","volume":"125","author":"Reynolds","year":"2010","journal-title":"Pharmacol Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2014.12.001_bb0145","first-page":"4","article-title":"The economic impact of schizophrenia","volume":"60","author":"Rice","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0150","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2010.07.012","article-title":"Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis","volume":"123","author":"Rummel-Kluge","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0155","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.lfs.2003.08.044","article-title":"The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia","volume":"74","author":"Ryan","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0160","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/schbul\/sbm141","article-title":"Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review","volume":"34","author":"Sentissi","year":"2008","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.psychres.2012.03.011","article-title":"Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients","volume":"199","author":"Smith","year":"2012","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0170","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eurpsy.2009.01.001","article-title":"How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins","volume":"24","author":"Starrenburg","year":"2009","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0175","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00702-005-0284-6","article-title":"A prospective study of serum ghrelin levels in patients treated with clozapine","volume":"112","author":"Theisen","year":"2005","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0180","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00213-003-1642-4","article-title":"Serum ghrelin concentrations in patients receiving olanzapine or risperidone","volume":"172","author":"Togo","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0185","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/13651501.2010.550400","article-title":"Association of serum levels of leptin, ghrelin, and adiponectin in schizophrenic patients and healthy controls","volume":"15","author":"Tsai","year":"2011","journal-title":"Int J Psychiatry Clin Pract"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0190","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0195","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1365-2362.2012.02702.x","article-title":"Hypertriglyceridemic waist, cytokines and hyperglycaemia in Chinese","volume":"42","author":"Yu","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.pnpbp.2014.12.001_bb0200","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.psyneuen.2013.07.010","article-title":"The role of ghrelin signalling in second-generation antipsychotic-induced weight gain","volume":"38","author":"Zhang","year":"2013","journal-title":"Psychoneuroendocrinology"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584614002383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584614002383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T14:54:34Z","timestamp":1690728874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584614002383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":40,"alternative-id":["S0278584614002383"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2014.12.001","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2014.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}